 | • レポートコード：MRC23Q36031 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：新技術 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の遺伝子疾患診断市場について調査・分析し、世界の遺伝子疾患診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ロボット放射線手術、分子標的薬使用、その他）、用途別セグメント分析（遺伝性疾患検査、薬理遺伝学的検査（PGx）、ヒト白血球抗原（HLA）検査、腫瘍学的検査、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Abbott Laboratories、Siemens Healthineers、Roche Diagnostics Corp、Bayer Diagnostics、Sysmex Corporation、Cephide、Bio-Rad Laboratories、Thermo Fisher Scientific、Illumina, Inc、Applied Biosystems、Transgenomic Inc、AutoGenomicsなどが含まれています。世界の遺伝子疾患診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、遺伝子疾患診断市場規模を推定する際に考慮しました。本レポートは、遺伝子疾患診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、遺伝子疾患診断に関するビジネス上の意思決定に役立てることを目的としています。 ・遺伝子疾患診断市場の概要 - 遺伝子疾患診断のタイプ別セグメント - 世界の遺伝子疾患診断市場規模：タイプ別分析（ロボット放射線手術、分子標的薬使用、その他） - 遺伝子疾患診断の用途別セグメント - 世界の遺伝子疾患診断市場規模：用途別分析（遺伝性疾患検査、薬理遺伝学的検査（PGx）、ヒト白血球抗原（HLA）検査、腫瘍学的検査、その他） - 世界の遺伝子疾患診断市場規模予測（2018年-2029年） ・遺伝子疾患診断市場の成長トレンド - 遺伝子疾患診断の地域別市場規模（2018年-2029年） - 遺伝子疾患診断市場ダイナミクス - 遺伝子疾患診断の業界動向 - 遺伝子疾患診断市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ロボット放射線手術、分子標的薬使用、その他 - 世界の遺伝子疾患診断のタイプ別市場規模（2018年-2023年） - 世界の遺伝子疾患診断のタイプ別市場規模（2024年-2029年） ・用途別セグメント：遺伝性疾患検査、薬理遺伝学的検査（PGx）、ヒト白血球抗原（HLA）検査、腫瘍学的検査、その他 - 世界の遺伝子疾患診断の用途別市場規模（2018年-2023年） - 世界の遺伝子疾患診断の用途別市場規模（2024年-2029年） ・遺伝子疾患診断の地域別市場規模 - 北米の遺伝子疾患診断市場規模（2018年-2029年） - アメリカの遺伝子疾患診断市場規模（2018年-2029年） - ヨーロッパの遺伝子疾患診断市場規模（2018年-2029年） - アジア太平洋の遺伝子疾患診断市場規模（2018年-2029年） - 中国の遺伝子疾患診断市場規模（2018年-2029年） - 日本の遺伝子疾患診断市場規模（2018年-2029年） - 韓国の遺伝子疾患診断市場規模（2018年-2029年） - インドの遺伝子疾患診断市場規模（2018年-2029年） - オーストラリアの遺伝子疾患診断市場規模（2018年-2029年） - 中南米の遺伝子疾患診断市場規模（2018年-2029年） - 中東・アフリカの遺伝子疾患診断市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Abbott Laboratories、Siemens Healthineers、Roche Diagnostics Corp、Bayer Diagnostics、Sysmex Corporation、Cephide、Bio-Rad Laboratories、Thermo Fisher Scientific、Illumina, Inc、Applied Biosystems、Transgenomic Inc、AutoGenomics ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Genetic Disease Diagnosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genetic Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genetic Disease Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genetic Disease Diagnosis in Inherited Disorder Testing is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genetic Disease Diagnosis include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics Corp, Bayer Diagnostics, Sysmex Corporation, Cephide, Bio-Rad Laboratories, Thermo Fisher Scientific and Illumina, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Disease Diagnosis.
The Genetic Disease Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Disease Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Siemens Healthineers
Roche Diagnostics Corp
Bayer Diagnostics
Sysmex Corporation
Cephide
Bio-Rad Laboratories
Thermo Fisher Scientific
Illumina, Inc
Applied Biosystems
Transgenomic Inc
AutoGenomics
Segment by Type
Robotic Radiosurgery
Usage Of Molecular Target Agents
Others
Segment by Application
Inherited Disorder Testing
Pharmacogenetic Testing (PGx)
Human Leukocyte Antigen (HLA) Testing
Oncology Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Robotic Radiosurgery
1.2.3 Usage Of Molecular Target Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Genetic Disease Diagnosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Inherited Disorder Testing
1.3.3 Pharmacogenetic Testing (PGx)
1.3.4 Human Leukocyte Antigen (HLA) Testing
1.3.5 Oncology Testing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Disease Diagnosis Market Perspective (2018-2029)
2.2 Genetic Disease Diagnosis Growth Trends by Region
2.2.1 Global Genetic Disease Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genetic Disease Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Genetic Disease Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Genetic Disease Diagnosis Market Dynamics
2.3.1 Genetic Disease Diagnosis Industry Trends
2.3.2 Genetic Disease Diagnosis Market Drivers
2.3.3 Genetic Disease Diagnosis Market Challenges
2.3.4 Genetic Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Diagnosis Players by Revenue
3.1.1 Global Top Genetic Disease Diagnosis Players by Revenue (2018-2023)
3.1.2 Global Genetic Disease Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Disease Diagnosis Revenue
3.4 Global Genetic Disease Diagnosis Market Concentration Ratio
3.4.1 Global Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Diagnosis Revenue in 2022
3.5 Genetic Disease Diagnosis Key Players Head office and Area Served
3.6 Key Players Genetic Disease Diagnosis Product Solution and Service
3.7 Date of Enter into Genetic Disease Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Disease Diagnosis Breakdown Data by Type
4.1 Global Genetic Disease Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Genetic Disease Diagnosis Forecasted Market Size by Type (2024-2029)
5 Genetic Disease Diagnosis Breakdown Data by Application
5.1 Global Genetic Disease Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Genetic Disease Diagnosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genetic Disease Diagnosis Market Size (2018-2029)
6.2 North America Genetic Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genetic Disease Diagnosis Market Size by Country (2018-2023)
6.4 North America Genetic Disease Diagnosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Disease Diagnosis Market Size (2018-2029)
7.2 Europe Genetic Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genetic Disease Diagnosis Market Size by Country (2018-2023)
7.4 Europe Genetic Disease Diagnosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Diagnosis Market Size (2018-2029)
8.2 Asia-Pacific Genetic Disease Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Genetic Disease Diagnosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Disease Diagnosis Market Size (2018-2029)
9.2 Latin America Genetic Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genetic Disease Diagnosis Market Size by Country (2018-2023)
9.4 Latin America Genetic Disease Diagnosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Diagnosis Market Size (2018-2029)
10.2 Middle East & Africa Genetic Disease Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Genetic Disease Diagnosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Genetic Disease Diagnosis Introduction
11.1.4 Abbott Laboratories Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Detail
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers Genetic Disease Diagnosis Introduction
11.2.4 Siemens Healthineers Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.2.5 Siemens Healthineers Recent Development
11.3 Roche Diagnostics Corp
11.3.1 Roche Diagnostics Corp Company Detail
11.3.2 Roche Diagnostics Corp Business Overview
11.3.3 Roche Diagnostics Corp Genetic Disease Diagnosis Introduction
11.3.4 Roche Diagnostics Corp Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.3.5 Roche Diagnostics Corp Recent Development
11.4 Bayer Diagnostics
11.4.1 Bayer Diagnostics Company Detail
11.4.2 Bayer Diagnostics Business Overview
11.4.3 Bayer Diagnostics Genetic Disease Diagnosis Introduction
11.4.4 Bayer Diagnostics Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.4.5 Bayer Diagnostics Recent Development
11.5 Sysmex Corporation
11.5.1 Sysmex Corporation Company Detail
11.5.2 Sysmex Corporation Business Overview
11.5.3 Sysmex Corporation Genetic Disease Diagnosis Introduction
11.5.4 Sysmex Corporation Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.5.5 Sysmex Corporation Recent Development
11.6 Cephide
11.6.1 Cephide Company Detail
11.6.2 Cephide Business Overview
11.6.3 Cephide Genetic Disease Diagnosis Introduction
11.6.4 Cephide Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.6.5 Cephide Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Genetic Disease Diagnosis Introduction
11.7.4 Bio-Rad Laboratories Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Genetic Disease Diagnosis Introduction
11.8.4 Thermo Fisher Scientific Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Illumina, Inc
11.9.1 Illumina, Inc Company Detail
11.9.2 Illumina, Inc Business Overview
11.9.3 Illumina, Inc Genetic Disease Diagnosis Introduction
11.9.4 Illumina, Inc Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.9.5 Illumina, Inc Recent Development
11.10 Applied Biosystems
11.10.1 Applied Biosystems Company Detail
11.10.2 Applied Biosystems Business Overview
11.10.3 Applied Biosystems Genetic Disease Diagnosis Introduction
11.10.4 Applied Biosystems Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.10.5 Applied Biosystems Recent Development
11.11 Transgenomic Inc
11.11.1 Transgenomic Inc Company Detail
11.11.2 Transgenomic Inc Business Overview
11.11.3 Transgenomic Inc Genetic Disease Diagnosis Introduction
11.11.4 Transgenomic Inc Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.11.5 Transgenomic Inc Recent Development
11.12 AutoGenomics
11.12.1 AutoGenomics Company Detail
11.12.2 AutoGenomics Business Overview
11.12.3 AutoGenomics Genetic Disease Diagnosis Introduction
11.12.4 AutoGenomics Revenue in Genetic Disease Diagnosis Business (2018-2023)
11.12.5 AutoGenomics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details